JDRF, Eli Lilly sign agreement to fund type 1 diabetes research for re-generative medicine
Links shared publicly online about this topic.
- 531total visits
JDRF, Eli Lilly sign agreement to fund type 1 diabetes research for re-generative medicine
Eli Lilly and Company and the Juvenile Diabetes Research Foundation today announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.
View full resource at news-medical.net
Tags: Diabetes, Type 1 Diabetes, Disease and Condition, Children's Health, Eli Lilly and Company, disease, Medical
Most Recently Shared on February 4, 2011 at 12:28 pm By:
JDRF, Eli Lilly sign agreement to fund type 1 diabetes research for re-generative medicine: Eli Lilly and Compan... http://bit.ly/grUw09
Regenerative Medicine Research In Type 1 Diabetes Funded By Lilly And JDRF Partnership
medicalnewstoday.com — “Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) have announced that they have signed an agreement to fund early-stage research that could enable patients wit” View full resource at medicalnewstoday.com
Most Recently Shared on February 7, 2011 at 1:39 pm By:
Scott Strumello Patient Expert
Regenerative Medicine Research In Type 1 Diabetes Funded By Lilly & JDRF Partnership: http://bit.ly/f0nxVV
Advertisement
